Cognitive functioning and predictors thereof in patients with 1–10 brain metastases selected for stereotactic radiosurgery

Purpose Information on predictive factors of cognitive functioning in patients with (multiple) brain metastases (BM) selected for radiosurgery may allow for more individual care and may play a role in predicting cognitive outcome after radiosurgery. The aim of this study was to evaluate cognitive pe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neuro-oncology 2019-11, Vol.145 (2), p.265-276
Hauptverfasser: Schimmel, Wietske C. M., Gehring, Karin, Hanssens, Patrick E. J., Sitskoorn, Margriet M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 276
container_issue 2
container_start_page 265
container_title Journal of neuro-oncology
container_volume 145
creator Schimmel, Wietske C. M.
Gehring, Karin
Hanssens, Patrick E. J.
Sitskoorn, Margriet M.
description Purpose Information on predictive factors of cognitive functioning in patients with (multiple) brain metastases (BM) selected for radiosurgery may allow for more individual care and may play a role in predicting cognitive outcome after radiosurgery. The aim of this study was to evaluate cognitive performance, and predictors thereof, in patients with 1–10 BM before radiosurgery. Methods Cognition was measured before radiosurgery using a standardized neuropsychological test battery in patients with 1–10 BM (expected survival > 3 months; KPS ≥ 70; no prior BM treatment). Regression formulae were constructed to calculate sociodemographically corrected z scores. Group and individual cognitive functioning was analyzed. Multivariable regression was used to explore potential predictors. Results Patients (N = 92) performed significantly worse than controls (N = 104) on all 11 test variables (medium-large effect sizes for 8 variables). Percentages of impairment were highest for information processing (55.3%), dexterity (43.2%) and cognitive flexibility (28.7%). 62% and 46% of patients had impairments in at least two, or three test variables, respectively. Models including combinations of clinical and psychological variables were predictive of verbal memory, psychomotor speed, information processing and dexterity. Neither number nor volume of metastases predicted patients’ test performance. Conclusions Already before radiosurgery, almost half of the patients suffered from severe cognitive deficits in at least three test variables. At group and individual level, information processing, cognitive flexibility, and dexterity were most affected. These cognitive impairments may impair daily functioning and patients’ ability to make (shared) treatment decisions. Both clinical (symptomatic BM; timing of BM diagnosis) and psychological (mental fatigue) characteristics influenced cognitive performance. Clinical trial information Cognition and Radiation Study A (CAR-Study A; ClinicalTrials.gov Identifier: NCT02953756; Medical Ethics Committee file number: NL53472.028.15/P1515).
doi_str_mv 10.1007/s11060-019-03292-y
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6856035</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2297125160</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-87ee2f351e94a93d187940a2f5912a2568420f63456d7755ac29336cd9c0ef2e3</originalsourceid><addsrcrecordid>eNp9kc2KFDEUhYMoTtv6Ai4k4GY2pflPZSNIM47CgBsFdyGTutWdoTppk9RIgwvfwTf0SSZtj-PPQghkcb9zcm4OQk8peUEJ0S8LpUSRjlDTEc4M6_b30IJKzTvNNb-PFoQq3UkjPp2gR6VcEUKE5vQhOuFUSib7foG-rtI6hhquAY9z9DWkGOIauzjgXYYh-JpywXUDGdKIQ8Q7VwPEWvCXUDeY_vj2nRJ8mV0bbaG60g4UXGACX2HAY8q41IO6uubucXZDSGXOa8j7x-jB6KYCT27vJfr45uzD6m138f783er1ReeFFrXrNQAbuaRghDN8oL02gjg2SkOZY1L1gpFRcSHVoLWUzjPDufKD8QRGBnyJXh19d_PlFgbf8mc32V0OW5f3Nrlg_57EsLHrdG1VLxXhshmc3hrk9HmGUu02FA_T5CKkuVjGjKZM0gYv0fN_0Ks059jWO1BKaNLyNoodKZ9TKRnGuzCU2EO59liubeXan-XafRM9-3ONO8mvNhvAj0Bpo9h--Pfb_7G9ASy4s6s</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2296470568</pqid></control><display><type>article</type><title>Cognitive functioning and predictors thereof in patients with 1–10 brain metastases selected for stereotactic radiosurgery</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Schimmel, Wietske C. M. ; Gehring, Karin ; Hanssens, Patrick E. J. ; Sitskoorn, Margriet M.</creator><creatorcontrib>Schimmel, Wietske C. M. ; Gehring, Karin ; Hanssens, Patrick E. J. ; Sitskoorn, Margriet M.</creatorcontrib><description>Purpose Information on predictive factors of cognitive functioning in patients with (multiple) brain metastases (BM) selected for radiosurgery may allow for more individual care and may play a role in predicting cognitive outcome after radiosurgery. The aim of this study was to evaluate cognitive performance, and predictors thereof, in patients with 1–10 BM before radiosurgery. Methods Cognition was measured before radiosurgery using a standardized neuropsychological test battery in patients with 1–10 BM (expected survival &gt; 3 months; KPS ≥ 70; no prior BM treatment). Regression formulae were constructed to calculate sociodemographically corrected z scores. Group and individual cognitive functioning was analyzed. Multivariable regression was used to explore potential predictors. Results Patients (N = 92) performed significantly worse than controls (N = 104) on all 11 test variables (medium-large effect sizes for 8 variables). Percentages of impairment were highest for information processing (55.3%), dexterity (43.2%) and cognitive flexibility (28.7%). 62% and 46% of patients had impairments in at least two, or three test variables, respectively. Models including combinations of clinical and psychological variables were predictive of verbal memory, psychomotor speed, information processing and dexterity. Neither number nor volume of metastases predicted patients’ test performance. Conclusions Already before radiosurgery, almost half of the patients suffered from severe cognitive deficits in at least three test variables. At group and individual level, information processing, cognitive flexibility, and dexterity were most affected. These cognitive impairments may impair daily functioning and patients’ ability to make (shared) treatment decisions. Both clinical (symptomatic BM; timing of BM diagnosis) and psychological (mental fatigue) characteristics influenced cognitive performance. Clinical trial information Cognition and Radiation Study A (CAR-Study A; ClinicalTrials.gov Identifier: NCT02953756; Medical Ethics Committee file number: NL53472.028.15/P1515).</description><identifier>ISSN: 0167-594X</identifier><identifier>EISSN: 1573-7373</identifier><identifier>DOI: 10.1007/s11060-019-03292-y</identifier><identifier>PMID: 31552588</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Brain cancer ; Brain Neoplasms - psychology ; Brain Neoplasms - radiotherapy ; Brain Neoplasms - secondary ; Clinical Study ; Cognition &amp; reasoning ; Cognitive ability ; Cognitive Dysfunction - diagnosis ; Cognitive Dysfunction - etiology ; Female ; Humans ; Information processing ; Longitudinal Studies ; Male ; Medicine ; Medicine &amp; Public Health ; Metastases ; Metastasis ; Middle Aged ; Neurology ; Neuropsychological Tests ; Oncology ; Patients ; Prognosis ; Prospective Studies ; Radiosurgery ; Radiosurgery - adverse effects</subject><ispartof>Journal of neuro-oncology, 2019-11, Vol.145 (2), p.265-276</ispartof><rights>The Author(s) 2019</rights><rights>Journal of Neuro-Oncology is a copyright of Springer, (2019). All Rights Reserved. © 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-87ee2f351e94a93d187940a2f5912a2568420f63456d7755ac29336cd9c0ef2e3</citedby><cites>FETCH-LOGICAL-c474t-87ee2f351e94a93d187940a2f5912a2568420f63456d7755ac29336cd9c0ef2e3</cites><orcidid>0000-0003-4689-2166 ; 0000-0002-6989-1855</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11060-019-03292-y$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11060-019-03292-y$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,315,782,786,887,27931,27932,41495,42564,51326</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31552588$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schimmel, Wietske C. M.</creatorcontrib><creatorcontrib>Gehring, Karin</creatorcontrib><creatorcontrib>Hanssens, Patrick E. J.</creatorcontrib><creatorcontrib>Sitskoorn, Margriet M.</creatorcontrib><title>Cognitive functioning and predictors thereof in patients with 1–10 brain metastases selected for stereotactic radiosurgery</title><title>Journal of neuro-oncology</title><addtitle>J Neurooncol</addtitle><addtitle>J Neurooncol</addtitle><description>Purpose Information on predictive factors of cognitive functioning in patients with (multiple) brain metastases (BM) selected for radiosurgery may allow for more individual care and may play a role in predicting cognitive outcome after radiosurgery. The aim of this study was to evaluate cognitive performance, and predictors thereof, in patients with 1–10 BM before radiosurgery. Methods Cognition was measured before radiosurgery using a standardized neuropsychological test battery in patients with 1–10 BM (expected survival &gt; 3 months; KPS ≥ 70; no prior BM treatment). Regression formulae were constructed to calculate sociodemographically corrected z scores. Group and individual cognitive functioning was analyzed. Multivariable regression was used to explore potential predictors. Results Patients (N = 92) performed significantly worse than controls (N = 104) on all 11 test variables (medium-large effect sizes for 8 variables). Percentages of impairment were highest for information processing (55.3%), dexterity (43.2%) and cognitive flexibility (28.7%). 62% and 46% of patients had impairments in at least two, or three test variables, respectively. Models including combinations of clinical and psychological variables were predictive of verbal memory, psychomotor speed, information processing and dexterity. Neither number nor volume of metastases predicted patients’ test performance. Conclusions Already before radiosurgery, almost half of the patients suffered from severe cognitive deficits in at least three test variables. At group and individual level, information processing, cognitive flexibility, and dexterity were most affected. These cognitive impairments may impair daily functioning and patients’ ability to make (shared) treatment decisions. Both clinical (symptomatic BM; timing of BM diagnosis) and psychological (mental fatigue) characteristics influenced cognitive performance. Clinical trial information Cognition and Radiation Study A (CAR-Study A; ClinicalTrials.gov Identifier: NCT02953756; Medical Ethics Committee file number: NL53472.028.15/P1515).</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Brain cancer</subject><subject>Brain Neoplasms - psychology</subject><subject>Brain Neoplasms - radiotherapy</subject><subject>Brain Neoplasms - secondary</subject><subject>Clinical Study</subject><subject>Cognition &amp; reasoning</subject><subject>Cognitive ability</subject><subject>Cognitive Dysfunction - diagnosis</subject><subject>Cognitive Dysfunction - etiology</subject><subject>Female</subject><subject>Humans</subject><subject>Information processing</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Neuropsychological Tests</subject><subject>Oncology</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>Radiosurgery</subject><subject>Radiosurgery - adverse effects</subject><issn>0167-594X</issn><issn>1573-7373</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kc2KFDEUhYMoTtv6Ai4k4GY2pflPZSNIM47CgBsFdyGTutWdoTppk9RIgwvfwTf0SSZtj-PPQghkcb9zcm4OQk8peUEJ0S8LpUSRjlDTEc4M6_b30IJKzTvNNb-PFoQq3UkjPp2gR6VcEUKE5vQhOuFUSib7foG-rtI6hhquAY9z9DWkGOIauzjgXYYh-JpywXUDGdKIQ8Q7VwPEWvCXUDeY_vj2nRJ8mV0bbaG60g4UXGACX2HAY8q41IO6uubucXZDSGXOa8j7x-jB6KYCT27vJfr45uzD6m138f783er1ReeFFrXrNQAbuaRghDN8oL02gjg2SkOZY1L1gpFRcSHVoLWUzjPDufKD8QRGBnyJXh19d_PlFgbf8mc32V0OW5f3Nrlg_57EsLHrdG1VLxXhshmc3hrk9HmGUu02FA_T5CKkuVjGjKZM0gYv0fN_0Ks059jWO1BKaNLyNoodKZ9TKRnGuzCU2EO59liubeXan-XafRM9-3ONO8mvNhvAj0Bpo9h--Pfb_7G9ASy4s6s</recordid><startdate>20191101</startdate><enddate>20191101</enddate><creator>Schimmel, Wietske C. M.</creator><creator>Gehring, Karin</creator><creator>Hanssens, Patrick E. J.</creator><creator>Sitskoorn, Margriet M.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4689-2166</orcidid><orcidid>https://orcid.org/0000-0002-6989-1855</orcidid></search><sort><creationdate>20191101</creationdate><title>Cognitive functioning and predictors thereof in patients with 1–10 brain metastases selected for stereotactic radiosurgery</title><author>Schimmel, Wietske C. M. ; Gehring, Karin ; Hanssens, Patrick E. J. ; Sitskoorn, Margriet M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-87ee2f351e94a93d187940a2f5912a2568420f63456d7755ac29336cd9c0ef2e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Brain cancer</topic><topic>Brain Neoplasms - psychology</topic><topic>Brain Neoplasms - radiotherapy</topic><topic>Brain Neoplasms - secondary</topic><topic>Clinical Study</topic><topic>Cognition &amp; reasoning</topic><topic>Cognitive ability</topic><topic>Cognitive Dysfunction - diagnosis</topic><topic>Cognitive Dysfunction - etiology</topic><topic>Female</topic><topic>Humans</topic><topic>Information processing</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Neuropsychological Tests</topic><topic>Oncology</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>Radiosurgery</topic><topic>Radiosurgery - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schimmel, Wietske C. M.</creatorcontrib><creatorcontrib>Gehring, Karin</creatorcontrib><creatorcontrib>Hanssens, Patrick E. J.</creatorcontrib><creatorcontrib>Sitskoorn, Margriet M.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of neuro-oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schimmel, Wietske C. M.</au><au>Gehring, Karin</au><au>Hanssens, Patrick E. J.</au><au>Sitskoorn, Margriet M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cognitive functioning and predictors thereof in patients with 1–10 brain metastases selected for stereotactic radiosurgery</atitle><jtitle>Journal of neuro-oncology</jtitle><stitle>J Neurooncol</stitle><addtitle>J Neurooncol</addtitle><date>2019-11-01</date><risdate>2019</risdate><volume>145</volume><issue>2</issue><spage>265</spage><epage>276</epage><pages>265-276</pages><issn>0167-594X</issn><eissn>1573-7373</eissn><abstract>Purpose Information on predictive factors of cognitive functioning in patients with (multiple) brain metastases (BM) selected for radiosurgery may allow for more individual care and may play a role in predicting cognitive outcome after radiosurgery. The aim of this study was to evaluate cognitive performance, and predictors thereof, in patients with 1–10 BM before radiosurgery. Methods Cognition was measured before radiosurgery using a standardized neuropsychological test battery in patients with 1–10 BM (expected survival &gt; 3 months; KPS ≥ 70; no prior BM treatment). Regression formulae were constructed to calculate sociodemographically corrected z scores. Group and individual cognitive functioning was analyzed. Multivariable regression was used to explore potential predictors. Results Patients (N = 92) performed significantly worse than controls (N = 104) on all 11 test variables (medium-large effect sizes for 8 variables). Percentages of impairment were highest for information processing (55.3%), dexterity (43.2%) and cognitive flexibility (28.7%). 62% and 46% of patients had impairments in at least two, or three test variables, respectively. Models including combinations of clinical and psychological variables were predictive of verbal memory, psychomotor speed, information processing and dexterity. Neither number nor volume of metastases predicted patients’ test performance. Conclusions Already before radiosurgery, almost half of the patients suffered from severe cognitive deficits in at least three test variables. At group and individual level, information processing, cognitive flexibility, and dexterity were most affected. These cognitive impairments may impair daily functioning and patients’ ability to make (shared) treatment decisions. Both clinical (symptomatic BM; timing of BM diagnosis) and psychological (mental fatigue) characteristics influenced cognitive performance. Clinical trial information Cognition and Radiation Study A (CAR-Study A; ClinicalTrials.gov Identifier: NCT02953756; Medical Ethics Committee file number: NL53472.028.15/P1515).</abstract><cop>New York</cop><pub>Springer US</pub><pmid>31552588</pmid><doi>10.1007/s11060-019-03292-y</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0003-4689-2166</orcidid><orcidid>https://orcid.org/0000-0002-6989-1855</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0167-594X
ispartof Journal of neuro-oncology, 2019-11, Vol.145 (2), p.265-276
issn 0167-594X
1573-7373
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6856035
source MEDLINE; SpringerNature Journals
subjects Adult
Aged
Aged, 80 and over
Brain cancer
Brain Neoplasms - psychology
Brain Neoplasms - radiotherapy
Brain Neoplasms - secondary
Clinical Study
Cognition & reasoning
Cognitive ability
Cognitive Dysfunction - diagnosis
Cognitive Dysfunction - etiology
Female
Humans
Information processing
Longitudinal Studies
Male
Medicine
Medicine & Public Health
Metastases
Metastasis
Middle Aged
Neurology
Neuropsychological Tests
Oncology
Patients
Prognosis
Prospective Studies
Radiosurgery
Radiosurgery - adverse effects
title Cognitive functioning and predictors thereof in patients with 1–10 brain metastases selected for stereotactic radiosurgery
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T21%3A25%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cognitive%20functioning%20and%20predictors%20thereof%20in%20patients%20with%201%E2%80%9310%20brain%20metastases%20selected%20for%20stereotactic%20radiosurgery&rft.jtitle=Journal%20of%20neuro-oncology&rft.au=Schimmel,%20Wietske%20C.%20M.&rft.date=2019-11-01&rft.volume=145&rft.issue=2&rft.spage=265&rft.epage=276&rft.pages=265-276&rft.issn=0167-594X&rft.eissn=1573-7373&rft_id=info:doi/10.1007/s11060-019-03292-y&rft_dat=%3Cproquest_pubme%3E2297125160%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2296470568&rft_id=info:pmid/31552588&rfr_iscdi=true